Andere Sprachen Ildong Holdings Co., Ltd.

Aktien

A000230

KR7000230003

A000230

Schlusskurs Korea S.E. Andere Börsenplätze 00:00:00 23.05.2024			% 5 Tage	% 1. Jan.
8 610 ^KRW	+1,65 %		+1,29 %	-18,16 %

14.03.	Ildong Holdings Co. Ltd. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr	CI
2023	Ildong Holdings Co. Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Ildong Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	14.03.
Ildong Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14.11.
Ildong Holdings Co., Ltd.(KOSE:A000230) dropped from S&P Global BMI Index	18.09.23
Ildong Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15.05.23
Shionogi & Co., Ltd. - New Drug Application of Ensitrelvir Fumaric Acid, a Therapeutic Drug for COVID-19 Accepted for Review in South Korea	05.01.23
Idience Co., Ltd announced that it has received KRW 14.9949886 billion in funding from Ildong Holdings Co., Ltd.	30.12.22
Idience Co., Ltd announced that it expects to receive KRW 14.9949886 billion in funding from Ildong Holdings Co., Ltd.	21.12.22
Ildong Holdings Co., Ltd. announced that it has received KRW 30 billion in funding	30.11.22
Ildong Holdings Co., Ltd. announced that it expects to receive KRW 30 billion in funding	15.11.22
Ildong Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14.11.22
Ildong Holdings Co., Ltd.(KOSE:A000230) added to S&P Global BMI Index	19.09.22
Execution of Sub-license Agreement from Ping An-Shionogi Hong Kong to Ildong for Ensitrelvir Fumaric Acid, a Therapeutic Drug for COVID-19, for South Korea	16.09.22
Ildong Holdings Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	16.08.22
Twist Bioscience, Ildong Pharmaceutical Partner to Discover Antibodies for Immuno-Oncology	30.06.22
Idience Co., Ltd announced that it expects to receive KRW 15.0050118 billion in funding from Ildong Holdings Co., Ltd., Yuanta Investment, Kiwoom Securities Co., Ltd., Investment Arm and other investors	28.06.22
Ildong Holdings Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	16.05.22
Ildong Holdings Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	17.03.22
Ildong : Prior Notice on Disclosure of Final Earnings	14.02.22
Ildong Holdings Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	15.11.21
Ildong Holdings Co., Ltd. acquired 5.18% stake in Ildong Pharmaceutical Co., Ltd. from Il-dong Foods Co. Ltd. and Lee, Keumki for KRW 22.4 billion.	27.02.19

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Ildong Holdings Co., Ltd.

Aktien

A000230

KR7000230003

A000230

Andere Sprachen

Filter